Ayal Hendel

Ramat Gan, TA, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Development of a Fully Non-Viral 1XX-enhanced BCMA CAR-T Cell Therapy for Multiple Myeloma.

Development of a Fully Non-Viral 1XX-enhanced BCMA CAR-T Cell Therapy for Multiple Myeloma.

Journal: bioRxiv : the preprint server for biology

Published: May 04, 2026

Development of a Fully Non-Viral 1XX-enhanced BCMA CAR-T Cell Therapy for Multiple Myeloma.

Development of a Fully Non-Viral 1XX-enhanced BCMA CAR-T Cell Therapy for Multiple Myeloma.

Journal: bioRxiv : the preprint server for biology

Published: May 04, 2026

Overcoming access barriers in European CAR-T therapy: the role of decentralized manufacturing and the EASYGEN framework.

Overcoming access barriers in European CAR-T therapy: the role of decentralized manufacturing and the EASYGEN framework.

Journal: Cytotherapy

Published: April 01, 2026

Modeling and correction of SCID-X1 using CRISPR-Cas9 homology-directed repair in human HSPCs.

Modeling and correction of SCID-X1 using CRISPR-Cas9 homology-directed repair in human HSPCs.

Journal: Molecular therapy. Nucleic acids

Published: January 08, 2026

Off-target effects in CRISPR-Cas genome editing for human therapeutics: Progress and challenges.

Off-target effects in CRISPR-Cas genome editing for human therapeutics: Progress and challenges.

Journal: Molecular therapy. Nucleic acids

Published: August 08, 2025

Proceedings of the second annual meeting of GenE-HumDi (COST Action 21113).

Proceedings of the second annual meeting of GenE-HumDi (COST Action 21113).

Journal: Frontiers in genome editing

Published: July 16, 2025

Gene-corrected regulatory T cell therapy for IL2RA deficiency.

Gene-corrected regulatory T cell therapy for IL2RA deficiency.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: June 02, 2025

Navigating disruption in the PID landscape: embracing opportunities and anticipating threats in the next ten years.

Navigating disruption in the PID landscape: embracing opportunities and anticipating threats in the next ten years.

Journal: Frontiers in immunology

Published: March 20, 2025

Precise measurement of CRISPR genome editing outcomes through single-cell DNA sequencing.

Precise measurement of CRISPR genome editing outcomes through single-cell DNA sequencing.

Journal: Molecular therapy. Methods & clinical development

Published: October 20, 2024

Evolution of Gene Therapy for Inborn Errors of Immunity.

Evolution of Gene Therapy for Inborn Errors of Immunity.

Journal: JAMA pediatrics

Published: May 20, 2024

Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi.

Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi.

Journal: Molecular therapy. Nucleic acids

Published: November 30, 2023

Quantifying allele-specific CRISPR editing activity with CRISPECTOR2.0.

Quantifying allele-specific CRISPR editing activity with CRISPECTOR2.0.

Journal: Nucleic acids research

Published: October 17, 2023

Showing 1-12 of 42

Last Updated: 09/26/2026